The global pharmaceutical industry experienced a 94% drop in company filings mentions of blockchain in Q1 2024 compared with the previous quarter, with the highest share accounted for by IQVIA, according to GlobalData鈥檚 analysis of over 18 pharmaceutical company filings. GlobalData’s Pharma: Filings Trends & Signals Q1 2024 report delves into earnings call transcripts and quarterly reports within the pharmaceuticals industry, extracting trends, signals, and comparative data to help businesses assess their performance, identify competitive intelligence, evaluate risks, and gain a comprehensive understanding of key industry events.
Notably, blockchain was one of the most frequently referenced themes in Q1 2024, ranking highest in terms of mentions, ahead of regtech and mobile health, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, IQVIA had the greatest increase in references for blockchain in Q1 2024, compared with the previous quarter. GlobalData identified one blockchain-related sentences in the company's filings - 0.1% of all sentences - and remained flat of 0% in Q1 2024 compared with Q1 2023.
GlobalData鈥檚 Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for blockchain in Q1 2024 was 119.
For further understanding of GlobalData's Pharma: Filings Trends & Signals Q1 2024,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData鈥檚 unrivalled proprietary data will enable you to decode what鈥檚 happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
